Monitoring free plasma concentrations of phenytoin.
作者信息
Peterson G M, McLean S
出版信息
Br J Clin Pharmacol. 1984 Dec;18(6):971-3. doi: 10.1111/j.1365-2125.1984.tb02576.x.
Abstract
摘要
相似文献
1
Monitoring free plasma concentrations of phenytoin.监测苯妥英的游离血浆浓度。
Br J Clin Pharmacol. 1984 Dec;18(6):971-3. doi: 10.1111/j.1365-2125.1984.tb02576.x.
2
The EMIT FreeLevel ultrafiltration technique compared with equilibrium dialysis and ultracentrifugation to determine protein binding of phenytoin.将EMIT FreeLevel超滤技术与平衡透析法和超速离心法进行比较，以测定苯妥英的蛋白结合率。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:61-70. doi: 10.2165/00003088-198400091-00008.
3
Neuropsychiatric toxicity of phenytoin. Importance of monitoring phenytoin levels.苯妥英钠的神经精神毒性。监测苯妥英钠血药浓度的重要性。
Clin Pediatr (Phila). 1993 Feb;32(2):107-10. doi: 10.1177/000992289303200210.
4
A rapid method for separation and estimation of free phenytoin in serum.一种血清中游离苯妥英的快速分离和测定方法。
Indian J Exp Biol. 1984 Nov;22(11):605-7.
5
Micro-scale ultracentrifugation as an alternative to ultrafiltration for the determination of the unbound fraction of phenytoin in human serum.
Ann Clin Biochem. 1986 Sep;23 ( Pt 5):603-7. doi: 10.1177/000456328602300519.
6
Plasma concentrations of unbound phenytoin in the management of epilepsy.癫痫治疗中游离苯妥英的血浆浓度
Br J Clin Pharmacol. 1984 May;17(5):539-46. doi: 10.1111/j.1365-2125.1984.tb02387.x.
7
Quantification of Free Phenytoin by Liquid Chromatography Tandem Mass Spectrometry (LC/MS/MS).采用液相色谱串联质谱法（LC/MS/MS）对游离苯妥英进行定量分析。
Methods Mol Biol. 2016;1383:241-6. doi: 10.1007/978-1-4939-3252-8_25.
8
Effect of ultrafiltration product and ultrafiltration-freezing sequence on free phenytoin determination.超滤产物和超滤-冷冻序列对游离苯妥英测定的影响。
Clin Pharm. 1991 Feb;10(2):132-6.
9
A pressure ultrafiltration method for serum free drug determination. Comparison with equilibrium dialysis using normal and uraemic sera.
Methods Find Exp Clin Pharmacol. 1984 Jan;6(1):51-5.
10
Hemodialysis of phenytoin in a uremic patient.尿毒症患者苯妥英钠的血液透析
Clin Pharmacol Ther. 1975 Jul;18(1):65-9. doi: 10.1002/cpt197518165.
引用本文的文献
1
Free drug concentration monitoring in clinical practice. Rationale and current status.临床实践中的游离药物浓度监测。原理与现状。
Clin Pharmacokinet. 1986 Nov-Dec;11(6):450-69. doi: 10.2165/00003088-198611060-00003.
本文引用的文献
1
Plasma protein binding of phenytoin in 100 epileptic patients.100例癫痫患者苯妥英钠的血浆蛋白结合情况
Br J Clin Pharmacol. 1982 Aug;14(2):298-300. doi: 10.1111/j.1365-2125.1982.tb01981.x.
2
Plasma protein binding of phenytoin in health and disease: relevance to therapeutic drug monitoring.健康与疾病状态下苯妥英的血浆蛋白结合：与治疗药物监测的相关性
Ther Drug Monit. 1980;2(4):331-44.
3
Should we routinely measure free plasma phenytoin concentration?我们应该常规测量游离血浆苯妥英浓度吗？
Br J Clin Pharmacol. 1984 Jan;17(1):99-102. doi: 10.1111/j.1365-2125.1984.tb05007.x.
4
Variability of phenytoin protein binding in epileptic patients.癫痫患者中苯妥英蛋白结合的变异性。
Arch Neurol. 1983 Aug;40(8):481-3. doi: 10.1001/archneur.1983.04210070021007.
5
Two-fold interindividual variation in plasma protein binding of phenytoin in patients with epilepsy.癫痫患者中苯妥英钠血浆蛋白结合的个体间差异达两倍。
Clin Pharmacokinet. 1976 Nov-Dec;1(6):444-52. doi: 10.2165/00003088-197601060-00004.
6
Frequency distribution of free warfarin and free phenytoin fraction values in serum of healthy human adults.
Clin Pharmacol Ther. 1977 Mar;21(3):283-6. doi: 10.1002/cpt1977213283.
7
Interindividual differences of protein binding in man.
Int J Clin Pharmacol Biopharm. 1979 Oct;17(10):392-5.
Zotero 插件